Cargando…

Booster vaccines for COVID-19 vaccine breakthrough cases? – Authors' reply

Detalles Bibliográficos
Autores principales:	Krause, Philip R, Rees, Helen, Figueroa, J Peter, Swaminathan, Soumya, Restrepo, Ana Maria Henao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947781/ https://www.ncbi.nlm.nih.gov/pubmed/35339221 http://dx.doi.org/10.1016/S0140-6736(22)00178-7

Ejemplares similares

Booster vaccines for COVID-19 vaccine breakthrough cases?
por: Nixon, Douglas F, et al.
Publicado: (2022)

The epidemiological relevance of the COVID-19-vaccinated population is decreasing after booster vaccination, as shown by incidence rate ratios—author's reply
por: Kampf, Günter
Publicado: (2022)

COVID-19 vaccination and HIV-1 acquisition – Authors’ reply
por: Buchbinder, Susan P, et al.
Publicado: (2022)

Misunderstanding poor adherence to COVID-19 vaccination in Africa – Authors' reply
por: Mutombo, Polydor Ngoy, et al.
Publicado: (2022)

COVID-19 vaccines: effectiveness and number needed to treat – Authors' reply
por: Olliaro, Piero, et al.
Publicado: (2021)

Timing and sequence of vaccination against COVID-19 and influenza – Author's reply
por: Dulfer, Elisabeth A., et al.
Publicado: (2023)

Authors’ Reply: Vaccination, payment, and COVID-19
por: Dotlic, Jelena, et al.
Publicado: (2021)

Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose
por: Kuhlmann, Constanze, et al.
Publicado: (2022)

Breakthrough infections in MPN-COVID vaccinated patients
por: Barbui, Tiziano, et al.
Publicado: (2022)

Safety and efficacy of the Russian COVID-19 vaccine: more information needed – Authors’ reply
por: Logunov, Denis Y, et al.
Publicado: (2020)

Authors' Reply to "Is Hib Vaccine of Economic Value in South Korea?"
por: Shin, Sangjin, et al.
Publicado: (2009)

Pausing drugs and spacing vaccines: an open question – Authors' reply
por: Rubbert-Roth, Andrea, et al.
Publicado: (2021)

Author reply
por: Graham, Philip
Publicado: (2018)

Author reply
por: Graham, Philip
Publicado: (2018)

Adverse event reporting and Bell's palsy risk after COVID-19 vaccination – Authors' reply
por: Wong, Ian Chi Kei, et al.
Publicado: (2021)

COVID-19 vaccine efficacy data: solid enough to delay second dose? – Authors' reply
por: Amit, Sharon, et al.
Publicado: (2021)

Withholding methotrexate after COVID-19 vaccination: different strategies, same results? – Author's reply
por: Mehta, Pankti, et al.
Publicado: (2022)

COVID-19 booster doses in pregnancy and global vaccine equity
por: Kalafat, Erkan, et al.
Publicado: (2022)

Author's Reply
por: Hoyt, Brian S, et al.
Publicado: (2014)

Neutralization of Omicron BA.4/BA.5 and BA.2.75 by booster vaccination or BA.2 breakthrough infection sera
por: Wang, Xun, et al.
Publicado: (2022)

Considerations in boosting COVID-19 vaccine immune responses
por: Krause, Philip R, et al.
Publicado: (2021)

Vaccines can save children with non-preventable diseases – Authors' reply
por: Gaythorpe, Katy A M, et al.
Publicado: (2021)

WHO prequalified tocilizumab and vaccine boosters against COVID-19
por: Rahimi, Farid, et al.
Publicado: (2022)

Booster vaccinations protect shipboard personnel from COVID-19
por: Ryan, Margaret, et al.
Publicado: (2022)

Is ipsilateral administration of COVID-19 vaccine boosters the optimal approach?
por: Ziegler, Laura, et al.
Publicado: (2023)

Cancer and COVID-19 – Authors' reply
por: Kuderer, Nicole M, et al.
Publicado: (2020)

Remdesivir and COVID-19 – Authors' reply
por: Wang, Yeming, et al.
Publicado: (2020)

Psychiatric and neuropsychiatric syndromes and COVID-19 – Authors' reply
por: Rogers, Jonathan P, et al.
Publicado: (2020)

Comparison of vaccine efficacy must be based on good clinical data–Authors’ reply
por: Abdul Taib, Nur Asheila, et al.
Publicado: (2022)

Making more COVID-19 vaccines available to address global needs: Considerations and a framework for their evaluation
por: Krause, Philip R, et al.
Publicado: (2022)

Breakthrough SARS-CoV-2 Infections in Prison after Vaccination
por: Brinkley-Rubinstein, Lauren, et al.
Publicado: (2021)

Combining immunomodulators and antivirals for COVID-19 – Authors' reply
por: Almansa, Raquel, et al.
Publicado: (2021)

Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines Against COVID-19 Hospitalizations: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Effect of anakinra in COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

COVID-19 in patients with HIV – Authors' reply
por: Miró, José M, et al.
Publicado: (2020)

COVID-19 and preterm birth – Authors' reply
por: Choudhary, Rahul, et al.
Publicado: (2021)

Neuropsychiatric disorders and COVID-19 – Authors' reply
por: Taquet, Maxime, et al.
Publicado: (2021)

COVID-19 and myocardial infarction – Authors' reply
por: Katsoularis, Ioannis, et al.
Publicado: (2021)

Fluvoxamine for the treatment of COVID-19 – Author's reply
por: Reis, Gilmar, et al.
Publicado: (2022)

Mavrilimumab for severe COVID-19 – Authors' reply
por: De Luca, Giacomo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ices5d12n8fiv7gfma0iunn6ig